{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:45:36Z","timestamp":1793493936366,"version":"4.5.0"},"reference-count":55,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NV16-30954A"],"award-info":[{"award-number":["NV16-30954A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NV18-03-00024"],"award-info":[{"award-number":["NV18-03-00024"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NV19-03-00279"],"award-info":[{"award-number":["NV19-03-00279"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["SVV 260516"],"award-info":[{"award-number":["SVV 260516"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["PROGRES Q28\/LF1"],"award-info":[{"award-number":["PROGRES Q28\/LF1"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004240","name":"Akademie V\u011bd \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["Strategie AV21, Qualitas"],"award-info":[{"award-number":["Strategie AV21, Qualitas"]}],"id":[{"id":"10.13039\/501100004240","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014809","name":"Technology Agency of the Czech Republic","doi-asserted-by":"publisher","award":["LM2018132"],"award-info":[{"award-number":["LM2018132"]}],"id":[{"id":"10.13039\/100014809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Operational Programme Research, Development and Education","award":["CZ.02.1.01\/0.0\/0.0\/18_046\/0015515"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/18_046\/0015515"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Cutaneous melanoma is the deadliest skin malignity with a rising prevalence worldwide. Patients carrying germline mutations in melanoma-susceptibility genes face an increased risk of melanoma and other cancers. To assess the spectrum of germline variants, we analyzed 264 Czech melanoma patients indicated for testing due to early melanoma (at &lt;25 years) or the presence of multiple primary melanoma\/melanoma and other cancer in their personal and\/or family history. All patients were analyzed by panel next-generation sequencing targeting 217 genes in four groups: high-to-moderate melanoma risk genes, low melanoma risk genes, cancer syndrome genes, and other genes with an uncertain melanoma risk. Population frequencies were assessed in 1479 population-matched controls. Selected POT1 and CHEK2 variants were characterized by functional assays. Mutations in clinically relevant genes were significantly more frequent in melanoma patients than in controls (31\/264; 11.7% vs. 58\/1479; 3.9%; p = 2.0 \u00d7 10\u22126). A total of 9 patients (3.4%) carried mutations in high-to-moderate melanoma risk genes (CDKN2A, POT1, ACD) and 22 (8.3%) patients in other cancer syndrome genes (NBN, BRCA1\/2, CHEK2, ATM, WRN, RB1). Mutations in high-to-moderate melanoma risk genes (OR = 52.2; 95%CI 6.6\u2013413.1; p = 3.2 \u00d7 10\u22127) and in other cancer syndrome genes (OR = 2.3; 95%CI 1.4\u20133.8; p = 0.003) were significantly associated with melanoma risk. We found an increased potential to carry these mutations (OR = 2.9; 95%CI 1.2\u20136.8) in patients with double primary melanoma, melanoma and other primary cancer, but not in patients with early age at onset. The analysis revealed affected genes in Czech melanoma patients and identified individuals who may benefit from genetic testing and future surveillance management of mutation carriers.<\/jats:p>","DOI":"10.3390\/biomedicines8100404","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T10:18:00Z","timestamp":1602497880000},"page":"404","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes"],"prefix":"10.3390","volume":"8","author":[{"given":"Lenka","family":"Stolarova","sequence":"first","affiliation":[{"name":"Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 53 Prague, Czech Republic"},{"name":"Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3993-4831","authenticated-orcid":false,"given":"Sandra","family":"Jelinkova","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 53 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radka","family":"Storchova","sequence":"additional","affiliation":[{"name":"Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0246-1471","authenticated-orcid":false,"given":"Eva","family":"Machackova","sequence":"additional","affiliation":[{"name":"Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Zemankova","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 53 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9386-657X","authenticated-orcid":false,"given":"Michal","family":"Vocka","sequence":"additional","affiliation":[{"name":"Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1382-2535","authenticated-orcid":false,"given":"Ondrej","family":"Kodet","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic"},{"name":"Institute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic"},{"name":"BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kral","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 53 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cerna","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 53 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Volkova","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 53 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Janatova","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 53 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2413-1542","authenticated-orcid":false,"given":"Jana","family":"Soukupova","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 53 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Stranecky","sequence":"additional","affiliation":[{"name":"Research Unit for Rare Diseases, Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 121 00 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Dundr","sequence":"additional","affiliation":[{"name":"Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 00 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Foretova","sequence":"additional","affiliation":[{"name":"Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0987-1238","authenticated-orcid":false,"given":"Libor","family":"Macurek","sequence":"additional","affiliation":[{"name":"Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kleiblova","sequence":"additional","affiliation":[{"name":"Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 00 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Kleibl","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 53 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1365-4632.2010.04474.x","article-title":"Review: Ultraviolet radiation and skin cancer","volume":"49","author":"Narayanan","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial Risk and Heritability of Cancer Among Twins in Nordic Countries","volume":"315","author":"Mucci","year":"2016","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.seminoncol.2016.08.003","article-title":"Genetic predisposition to melanoma","volume":"43","author":"Hawkes","year":"2016","journal-title":"Semin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bbadis.2014.01.016","article-title":"ARF tumor suppression in the nucleolus","volume":"1842","author":"Maggi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ng0795-351","article-title":"Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds","volume":"10","author":"Gruis","year":"1995","journal-title":"Nat. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-genom-091212-153429","article-title":"The Genetics of Melanoma: Recent Advances","volume":"14","author":"Hill","year":"2013","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jid.2019.06.138","article-title":"Variation in Cutaneous Patterns of Melanomagenesis According to Germline CDKN2A\/CDK4 Status in Melanoma-Prone Families","volume":"140","author":"Sargen","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.canlet.2016.05.011","article-title":"CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma","volume":"378","author":"Betti","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","article-title":"Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma","volume":"12","author":"Zuo","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and Cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1093\/hmg\/ddx368","article-title":"Rare germline variants in known melanoma susceptibility genes in familial melanoma","volume":"26","author":"Goldstein","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10689-015-9841-9","article-title":"Germline TERT promoter mutations are rare in familial melanoma","volume":"15","author":"Harland","year":"2015","journal-title":"Fam. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10555-017-9661-5","article-title":"Identification, genetic testing, and management of hereditary melanoma","volume":"36","author":"Leachman","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/jnci\/djr219","article-title":"Comprehensive Field Synopsis and Systematic Meta-analyses of Genetic Association Studies in Cutaneous Melanoma","volume":"103","author":"Chatzinasiou","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ng.3373","article-title":"Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma","volume":"47","author":"Law","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/bjd.17917","article-title":"Genome-wide association studies and polygenic risk scores for skin cancer: Clinically useful yet?","volume":"181","author":"Roberts","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.14735\/amko2014406","article-title":"Cancer incidence and mortality in the Czech Republic","volume":"27","author":"Melichar","year":"2014","journal-title":"Klin. Onkol."},{"key":"ref_21","unstructured":"Krejci, D., Zapletalova, M., Svobodova, I., Pehalova, L., Muzik, J., Klimes, D., Snajdrova, L., Bajciova, V., Mudry, P., and Kodytkova, D. (2019). Epidemiological Trends for Childhood and Adolescent Cancers in the Period 1994\u20132016 in the Czech Republic. Klin. Onkol., 32."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2015.08.038","article-title":"Hereditary melanoma: Update on syndromes and management","volume":"74","author":"Soura","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2015.08.037","article-title":"Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling","volume":"74","author":"Soura","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2015-103150","article-title":"Melanoma genetics","volume":"53","author":"Read","year":"2015","journal-title":"J. Med Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/bioinformatics\/btp618","article-title":"Phenopedia and Genopedia: Disease-centered and gene-centered views of the evolving knowledge of human genetic associations","volume":"26","author":"Yu","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/cge.12748","article-title":"Hereditary truncating mutations of DNA repair and other genes in BRCA1\/BRCA2\/PALB2 -negatively tested breast cancer patients","volume":"90","author":"Lhota","year":"2016","journal-title":"Clin. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Soukupova, J., Zemankova, P., Lhotova, K., Janatova, M., Borecka, M., Stolarova, L., Lhota, F., Foretova, L., Machackova, E., and Stranecky, V. (2018). Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195761"},{"key":"ref_28","first-page":"405","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genetics"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Walker, L.C., Lattimore, V.L., Kvist, A., Kleiblova, P., Zemankova, P., De Jong, L., Wiggins, G.A.R., Hakkaart, C., Cree, S.L., and Behar, R. (2019). Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing with Implications for Variant Classification. Front. Genet., 10.","DOI":"10.3389\/fgene.2019.01139"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/ijc.32385","article-title":"Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer","volume":"145","author":"Kleiblova","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.celrep.2017.08.020","article-title":"NEIL3 Repairs Telomere Damage during S Phase to Secure Chromosome Segregation at Mitosis","volume":"20","author":"Zhou","year":"2017","journal-title":"Cell Rep."},{"key":"ref_32","first-page":"1013","article-title":"POT1 as a terminal transducer of TRF1 telomere length control","volume":"423","author":"Loayza","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ejhg.2017.134","article-title":"The wide spectrum of POT1 gene variants correlates with multiple cancer types","volume":"25","author":"Calvete","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nsmb867","article-title":"Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection","volume":"11","author":"Lei","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/pcmr.12333","article-title":"Genetics of familial melanoma: 20 years after CDKN2A","volume":"28","author":"Aoude","year":"2015","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents","volume":"44","author":"Goldstein","year":"2006","journal-title":"J. Med Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.molcel.2015.12.016","article-title":"TPP1 Blocks an ATR-Mediated Resection Mechanism at Telomeres","volume":"61","author":"Kibe","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1128\/MCB.00286-09","article-title":"POT1 Association with TRF2 Regulates Telomere Length","volume":"29","author":"Kendellen","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Calvete, O., Mart\u00ednez, P., Garc\u00eda-Pav\u00eda, P., Benitez-Buelga, C., Paumard, B., Fernandez, V., Dom\u00ednguez, F., Salas, C., Romero-Laorden, N., and Garc\u00eda-Don\u00e1s, J. (2015). A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li\u2013Fraumeni-like families. Nat. Commun., 6.","DOI":"10.1038\/ncomms9383"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Richard, M.A., Lupo, P.J., Morton, L.M., Yasui, Y.A., Sapkota, Y.A., Arnold, M.A., Aubert, G., Neglia, J.P., Turcotte, L.M., and Leisenring, W.M. (2020). Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0228887"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Srivastava, A., Miao, B., Skopelitou, D., Kumar, V., Kumar, A., Paramasivam, N., Bonora, E., Hemminki, K., F\u00f6rsti, A., and Bandapalli, O.R. (2020). A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer. Cancers, 12.","DOI":"10.1101\/2020.03.23.004663"},{"key":"ref_42","first-page":"1","article-title":"A new POT1 germline mutation\u2014Expanding the spectrum of POT1-associated cancers","volume":"53","author":"Wilson","year":"2017","journal-title":"Fam. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1089\/thy.2019.0156","article-title":"A Truncating Germline Mutation of TINF2 in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres","volume":"30","author":"He","year":"2020","journal-title":"Thyroid"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Aoude, L.G., Pritchard, A.L., Robles-Espinoza, C.D., Wadt, K., Harland, M., Choi, J., Gartside, M., Quesada, V., A Johansson, P., and Palmer, J.M. (2015). Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma. J. Natl. Cancer Inst., 107.","DOI":"10.1093\/jnci\/dju408"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Pastorino, L., Andreotti, V., Dalmasso, B., Vanni, I., Ciccarese, G., Mandal\u00e0, M., Spadola, G., Pizzichetta, M.A., Ponti, G., and Tibiletti, M.G. (2020). Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1. Cancers, 12.","DOI":"10.3390\/cancers12041007"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.14735\/amko2016S35","article-title":"Retrospective NGS Study in High-risk Hereditary Cancer Patients at Masaryk Memorial Cancer Institute","volume":"29","author":"Svoboda","year":"2016","journal-title":"Klin. Onkol."},{"key":"ref_47","first-page":"118","article-title":"BAP1 Syndrome\u2014Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers","volume":"32","author":"Svoboda","year":"2019","journal-title":"Klin. Onkol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/humu.23955","article-title":"DNA repair functional analyses of NBN hypomorphic variants associated with NBN-related infertility","volume":"41","author":"Bellanger","year":"2020","journal-title":"Hum. Mutat."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Lhotova, K., Stolarova, L., Zemankova, P., Vo\u010dka, M., Janatova, M., Borecka, M., Cerna, M., Jelinkova, S., Kral, J., and Volkova, Z. (2020). Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer. Cancers, 12.","DOI":"10.3390\/cancers12040956"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00008390-200308000-00005","article-title":"Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin","volume":"13","author":"Cybulski","year":"2003","journal-title":"Melanoma Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ijc.20239","article-title":"Increased cancer risk of heterozygotes withNBS1 germline mutations in poland","volume":"111","author":"Steffen","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/CMR.0b013e3280dec638","article-title":"Molecular genetic analysis of NBS1 in German melanoma patients","volume":"17","author":"Meyer","year":"2007","journal-title":"Melanoma Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10689-017-9982-0","article-title":"A case of contralateral breast cancer and skin cancer associated with NBN heterozygous pathogenic variant c.698_701delAACA","volume":"2013","author":"Gass","year":"2017","journal-title":"Fam. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/pcmr.12833","article-title":"Melanoma predisposition\u2014A limited role for germline BRCA1 and BRCA2 variants","volume":"33","author":"Adams","year":"2019","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Bui, A.-T.N., Leboeuf, N.R., and Nambudiri, V.E. (2020). Skin cancer risk in CHEK2 mutation carriers. J. Eur. Acad. Dermatol. Venereol.","DOI":"10.1111\/jdv.16729"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/10\/404\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:18:04Z","timestamp":1760177884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/10\/404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["biomedicines8100404"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines8100404","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]}}}